BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19065635)

  • 1. Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
    Melnikov AA; Scholtens D; Talamonti MS; Bentrem DJ; Levenson VV
    J Surg Oncol; 2009 Feb; 99(2):119-22. PubMed ID: 19065635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
    Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
    Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible detection of pancreatic cancer by plasma protein profiling.
    Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; Kikuchi S; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Hirohashi S; Yamada T
    Cancer Res; 2005 Nov; 65(22):10613-22. PubMed ID: 16288055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.
    Park JK; Ryu JK; Lee KH; Lee JK; Yoon WJ; Lee SH; Yoo JW; Woo SM; Lee GY; Lee CH; Kim YT; Yoon YB
    Pancreas; 2007 Oct; 35(3):e9-15. PubMed ID: 17895837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells.
    Ishikawa M; Yoshida K; Yamashita Y; Ota J; Takada S; Kisanuki H; Koinuma K; Choi YL; Kaneda R; Iwao T; Tamada K; Sugano K; Mano H
    Cancer Sci; 2005 Jul; 96(7):387-93. PubMed ID: 16053509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles.
    Huang H; Dong X; Kang MX; Xu B; Chen Y; Zhang B; Chen J; Xie QP; Wu YL
    Am J Gastroenterol; 2010 Jul; 105(7):1661-9. PubMed ID: 20571492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Array-based multiplex analysis of DNA methylation in breast cancer tissues.
    Melnikov AA; Scholtens DM; Wiley EL; Khan SA; Levenson VV
    J Mol Diagn; 2008 Jan; 10(1):93-101. PubMed ID: 18165279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
    Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
    Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.
    Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K
    Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
    Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
    Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum biomarker signatures associated with pancreatic cancer.
    Wingren C; Sandström A; Segersvärd R; Carlsson A; Andersson R; Löhr M; Borrebaeck CA
    Cancer Res; 2012 May; 72(10):2481-90. PubMed ID: 22589272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.